These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25731732)

  • 21. miR-142-3p Suppresses Cell Growth by Targeting CDK4 in Colorectal Cancer.
    Zhu X; Ma SP; Yang D; Liu Y; Wang YP; Lin T; Li YX; Yang SH; Zhang WC; Wang XL
    Cell Physiol Biochem; 2018; 51(4):1969-1981. PubMed ID: 30513513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-196a post-transcriptionally upregulates the UBE2C proto-oncogene and promotes cell proliferation in breast cancer.
    Han Q; Zhou C; Liu F; Xu G; Zheng R; Zhang X
    Oncol Rep; 2015 Aug; 34(2):877-83. PubMed ID: 26062455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [miR-101 inhibits the proliferation and migration of breast cancer cells via downregulating the expression of DNA methyltransferase 3a].
    Liu J; Pang Y; Wang H; Li Y; Sun X; Xu F; Ren H; Liu D
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):299-303. PubMed ID: 26927545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1.
    Yao Y; Hu J; Shen Z; Yao R; Liu S; Li Y; Cong H; Wang X; Qiu W; Yue L
    J Cell Mol Med; 2015 Apr; 19(4):760-9. PubMed ID: 25639535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. microRNA-335 inhibits proliferation, cell-cycle progression, colony formation, and invasion via targeting PAX6 in breast cancer cells.
    Meng Y; Zou Q; Liu T; Cai X; Huang Y; Pan J
    Mol Med Rep; 2015 Jan; 11(1):379-85. PubMed ID: 25323813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.
    Luo Q; Li X; Li J; Kong X; Zhang J; Chen L; Huang Y; Fang L
    Int J Oncol; 2013 Oct; 43(4):1212-8. PubMed ID: 23900351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-206 is down-regulated in breast cancer and inhibits cell proliferation through the up-regulation of cyclinD2.
    Zhou J; Tian Y; Li J; Lu B; Sun M; Zou Y; Kong R; Luo Y; Shi Y; Wang K; Ji G
    Biochem Biophys Res Commun; 2013 Apr; 433(2):207-12. PubMed ID: 23466356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-613 induces cell cycle arrest by targeting CDK4 in non-small cell lung cancer.
    Li D; Li DQ; Liu D; Tang XJ
    Cell Oncol (Dordr); 2016 Apr; 39(2):139-47. PubMed ID: 26744345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells.
    Wang X; Li Y; Qi W; Zhang N; Sun M; Huo Q; Cai C; Lv S; Yang Q
    Oncotarget; 2015 Oct; 6(32):32737-47. PubMed ID: 26417931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-545 suppresses cell proliferation by targeting cyclin D1 and CDK4 in lung cancer cells.
    Du B; Wang Z; Zhang X; Feng S; Wang G; He J; Zhang B
    PLoS One; 2014; 9(2):e88022. PubMed ID: 24505359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-1301-3p inhibits human breast cancer cell proliferation by regulating cell cycle progression and apoptosis through directly targeting ICT1.
    Peng X; Yan B; Shen Y
    Breast Cancer; 2018 Nov; 25(6):742-752. PubMed ID: 29951881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-503 inhibited cell proliferation of human breast cancer cells by suppressing CCND1 expression.
    Long J; Ou C; Xia H; Zhu Y; Liu D
    Tumour Biol; 2015 Nov; 36(11):8697-702. PubMed ID: 26047605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. microRNA-762 promotes breast cancer cell proliferation and invasion by targeting IRF7 expression.
    Li Y; Huang R; Wang L; Hao J; Zhang Q; Ling R; Yun J
    Cell Prolif; 2015 Dec; 48(6):643-9. PubMed ID: 26597380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. microRNA miR-142-3p Inhibits Breast Cancer Cell Invasiveness by Synchronous Targeting of WASL, Integrin Alpha V, and Additional Cytoskeletal Elements.
    Schwickert A; Weghake E; Brüggemann K; Engbers A; Brinkmann BF; Kemper B; Seggewiß J; Stock C; Ebnet K; Kiesel L; Riethmüller C; Götte M
    PLoS One; 2015; 10(12):e0143993. PubMed ID: 26657485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-455 inhibits breast cancer cell proliferation through targeting CDK14.
    Wang B; Zou A; Ma L; Chen X; Wang L; Zeng X; Tan T
    Eur J Pharmacol; 2017 Jul; 807():138-143. PubMed ID: 28300591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The highly expressed 5'isomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migration.
    Salem O; Erdem N; Jung J; Münstermann E; Wörner A; Wilhelm H; Wiemann S; Körner C
    BMC Genomics; 2016 Aug; 17():566. PubMed ID: 27502506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of the long non-coding RNA TUG1 is associated with cell proliferation, migration, and invasion in breast cancer.
    Fan S; Yang Z; Ke Z; Huang K; Liu N; Fang X; Wang K
    Biomed Pharmacother; 2017 Nov; 95():1636-1643. PubMed ID: 28950664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-519d-mediated downregulation of STAT3 suppresses breast cancer progression.
    Deng X; Zhao Y; Wang B
    Oncol Rep; 2015 Oct; 34(4):2188-94. PubMed ID: 26238950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-suppressive miRNA-135a inhibits breast cancer cell proliferation by targeting ELK1 and ELK3 oncogenes.
    Ahmad A; Zhang W; Wu M; Tan S; Zhu T
    Genes Genomics; 2018 Mar; 40(3):243-251. PubMed ID: 29892795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition.
    Zhang Y; Wang Y; Wei Y; Li M; Yu S; Ye M; Zhang H; Chen S; Liu W; Zhang J
    Sci Rep; 2015 Oct; 5():15424. PubMed ID: 26487539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.